Rimegepant for vestibular migraine
Treatments studied
Part of Brain & nervous system, Ear, nose & throat clinical trials.
This trial tests whether rimegepant, a medicine usually used for migraine headaches, can help reduce dizziness attacks in people with vestibular migraine. If you have frequent dizziness and have not found enough relief from other preventive treatments, this study may be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with vestibular migraine by a doctor.
- You have more than 4 days of dizziness per month in the last 3 months.
- You have tried at least one other migraine prevention medicine but it did not work well enough.
- You are not pregnant or breastfeeding, and you are willing to use birth control during the study.
- You have not tried rimegepant or any CGRP-blocking medicine before, and you are not allergic to rimegepant or its ingredients.
- You do not have another cause of dizziness (like Meniere's disease or vestibular neuritis) and have not had ear surgery (except ear tubes).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called rimegepant to see if it quickly relieves vertigo and dizziness during a vestibular migraine attack. Vestibular migraine causes symptoms like spinning or imbalance, often with headache. If you have frequent, moderate-to-severe episodes, this treatment might offer relief.
This study compares two oral medications—rimegepant and flunarizine—to see how well they prevent dizzy or vertigo episodes in people with vestibular migraine. You will take one of the two medicines daily for several months, and track your symptoms on a smartphone app.
This study will track how current treatments work for adults with vestibular migraine, a condition where migraine causes dizziness and balance problems. It may help doctors learn which options help most in everyday life.
This study tests a medication called rimegepant (a CGRP blocker) as a treatment for sudden dizziness attacks that come with migraine-like symptoms. If you have these kinds of dizzy spells, this trial may help find out if the drug can stop them quickly.
This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
Hear when a new Vestibular Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.